{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:12:43Z","timestamp":1790802763476,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ursodeoxycholic acid (UDCA) treatment can reduce itch and lower endogenous serum bile acids in intrahepatic cholestasis of pregnancy (ICP). We sought to determine how it could influence the gut environment in ICP to alter enterohepatic signalling. The gut microbiota and bile acid content were determined in faeces from 35 pregnant women (14 with uncomplicated pregnancies and 21 with ICP, 17 receiving UDCA). Faecal bile salt hydrolase activity was measured using a precipitation assay. Serum fibroblast growth factor 19 (FGF19) and 7\u03b1-hydroxy-4-cholesten-3-one (C4) concentrations were measured following a standardised diet for 21\u2009hours. Women with a high ratio of<jats:italic>Bacteroidetes<\/jats:italic>to<jats:italic>Firmicutes<\/jats:italic>were more likely to be treated with UDCA (Fisher\u2019s exact test p\u2009=\u20090.0178) than those with a lower ratio. Bile salt hydrolase activity was reduced in women with low<jats:italic>Bacteroidetes<\/jats:italic>:<jats:italic>Firmicutes<\/jats:italic>. Women taking UDCA had higher faecal lithocholic acid (p\u2009&lt;\u20090.0001), with more unconjugated bile acids than women with untreated ICP or uncomplicated pregnancy. UDCA-treatment increased serum FGF19, and reduced C4 (reflecting lower bile acid synthesis). During ICP, UDCA treatment can be associated with enrichment of the gut microbiota with<jats:italic>Bacteroidetes<\/jats:italic>. These demonstrate high bile salt hydrolase activity, which deconjugates bile acids enabling secondary modification to FXR agonists, enhancing enterohepatic feedback via FGF19.<\/jats:p>","DOI":"10.1038\/s41598-020-60821-w","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T11:03:21Z","timestamp":1583233401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy"],"prefix":"10.1038","volume":"10","author":[{"given":"Caroline","family":"Ovadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Perdones-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hei Man","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Mullish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A. K.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Papacleovoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Wahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"St\u00e5hlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Tsakmaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C. D.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Sklavounos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin A.","family":"Bewick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R. F.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Ulrich","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"60821_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks, D. J. et al. Bile acids: natural ligands for an orphan nuclear receptor. Sci. 284, 1365\u20131368 (1999).","journal-title":"Sci."},{"key":"60821_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"60821_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","volume":"298","author":"T Maruyama","year":"2002","unstructured":"Maruyama, T. et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Comm. 298, 714\u2013719 (2002).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"60821_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz, A., Marschall, H. U. & Mattsson, L. A. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40, 467\u2013474 (2004).","journal-title":"Hepatology"},{"key":"60821_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia, C. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 393, 899\u2013909 (2019).","journal-title":"Lancet"},{"key":"60821_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2337\/dc14-2143","volume":"38","author":"MG Martineau","year":"2015","unstructured":"Martineau, M. G. et al. The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 38, 243\u2013248 (2015).","journal-title":"Diabetes Care"},{"key":"60821_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.AOG.0000189096.94874.9c","volume":"107","author":"AT Dann","year":"2006","unstructured":"Dann, A. T. et al. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 107, 106\u2013114 (2006).","journal-title":"Obstet. Gynecol."},{"key":"60821_CR8","doi-asserted-by":"publisher","first-page":"e4949","DOI":"10.1097\/MD.0000000000004949","volume":"95","author":"X Kong","year":"2016","unstructured":"Kong, X., Kong, Y., Zhang, F., Wang, T. & Yan, J. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). Med. 95, e4949 (2016).","journal-title":"Med."},{"key":"60821_CR9","doi-asserted-by":"publisher","first-page":"e83828","DOI":"10.1371\/journal.pone.0083828","volume":"9","author":"V Geenes","year":"2014","unstructured":"Geenes, V. et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS One 9, e83828 (2014).","journal-title":"PLoS One"},{"key":"60821_CR10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.metabol.2011.10.023","volume":"61","author":"T Tsuchida","year":"2012","unstructured":"Tsuchida, T., Shiraishi, M., Ohta, T., Sakai, K. & Ishii, S. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet\u2013fed KK-Ay mice. Metab. 61, 944\u2013953 (2012).","journal-title":"Metab."},{"key":"60821_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2012.07.008","volume":"150","author":"O Koren","year":"2012","unstructured":"Koren, O. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150, 470\u2013480 (2012).","journal-title":"Cell"},{"key":"60821_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/19490976.2015.1086056","volume":"6","author":"W Gohir","year":"2015","unstructured":"Gohir, W. et al. Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother\u2019s periconceptional diet. Gut Microbes 6, 310\u2013320 (2015).","journal-title":"Gut Microbes"},{"key":"60821_CR13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hep.30661","volume":"70","author":"C Ovadia","year":"2019","unstructured":"Ovadia, C. et al. Enhanced microbial bile acid deconjugation and impaired ileal uptake in pregnancy repress intestinal regulation of bile acid synthesis. Hepatology 70, 276\u2013293 (2019).","journal-title":"Hepatology"},{"key":"60821_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/hep.23849","volume":"52","author":"A Milona","year":"2010","unstructured":"Milona, A. et al. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 52, 1341\u20131349 (2010).","journal-title":"Hepatology"},{"key":"60821_CR15","unstructured":"Manna, L., et al. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. BJOG 10.111\/1471-0528.15926 (2019)."},{"key":"60821_CR16","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers, U., Trauner, M., Jansen, P. & Poupon, R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J. Hepatol. 62, S25\u2013S37 (2015).","journal-title":"J. Hepatol."},{"key":"60821_CR17","doi-asserted-by":"publisher","first-page":"e00368","DOI":"10.1002\/prp2.368","volume":"5","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models. Pharmacol. Res. Perspect. 5, e00368 (2017).","journal-title":"Pharmacol. Res. Perspect."},{"key":"60821_CR18","doi-asserted-by":"publisher","first-page":"G940","DOI":"10.1152\/ajpgi.00398.2012","volume":"304","author":"JH Zhang","year":"2013","unstructured":"Zhang, J. H. et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am. J. Physiol. Gastrointest. Liver Physiol 304, G940\u2013G948 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"60821_CR19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-2275(20)37344-2","volume":"22","author":"S Hirano","year":"1981","unstructured":"Hirano, S., Masuda, N. & Oda, H. In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids. J. Lipid Res. 22, 735\u2013743 (1981).","journal-title":"J. Lipid Res."},{"key":"60821_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00003088-199630050-00002","volume":"30","author":"A Crosignani","year":"1996","unstructured":"Crosignani, A. et al. Clinical pharmacokinetics of therapeutic bile acids. Clin. Pharmacokinet. 30, 333\u2013358 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"60821_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0168-8278(98)80207-9","volume":"28","author":"D Brites","year":"1998","unstructured":"Brites, D. et al. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J. Hepatol. 28, 91\u201398 (1998).","journal-title":"J. Hepatol."},{"key":"60821_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35496-z","volume":"8","author":"RM Gadaleta","year":"2018","unstructured":"Gadaleta, R. M. et al. Suppression of hepatic bile acid synthesis by a non-tumorigenic FGF19 analogue protects mice from fibrosis and hepatocarcinogenesis. Sci. Rep. 8, 17210 (2018).","journal-title":"Sci. Rep."},{"key":"60821_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller, M. et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J. Hepatol. 62, 1398\u20131404 (2015).","journal-title":"J. Hepatol."},{"key":"60821_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10166","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang, C. et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6, 10166 (2015).","journal-title":"Nat. Commun."},{"key":"60821_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ppe.12248","volume":"30","author":"J Mets\u00e4l\u00e4","year":"2016","unstructured":"Mets\u00e4l\u00e4, J., Stach-Lempinen, B., Gissler, M., Eriksson, J. G. & Koivusalo, S. Risk of pregnancy complications in relation to maternal prepregnancy body mass index: population-based study from Finland 2006-10. Paediatr. Perinat. Epidemiol. 30, 28\u201337 (2016).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"60821_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nat. 444, 1022\u20131023 (2006).","journal-title":"Nat."},{"key":"60821_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nat. 457, 480\u2013484 (2009).","journal-title":"Nat."},{"key":"60821_CR28","doi-asserted-by":"publisher","first-page":"e7125","DOI":"10.1371\/journal.pone.0007125","volume":"4","author":"F Armougom","year":"2009","unstructured":"Armougom, F., Henry, M., Vialettes, B., Raccah, D. & Raoult, D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 4, e7125 (2009).","journal-title":"PLoS One"},{"key":"60821_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3748\/wjg.v17.i8.1076","volume":"17","author":"H-J Zuo","year":"2011","unstructured":"Zuo, H.-J. et al. Gut bacteria alteration in obese people and its relationship with gene polymorphism. World J. Gastroenterol. 17, 1076\u20131081 (2011).","journal-title":"World J. Gastroenterol."},{"key":"60821_CR30","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1136\/gutjnl-2018-317842","volume":"68","author":"BH Mullish","year":"2019","unstructured":"Mullish, B. H. et al. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the teratment of recurrent Clostridioides difficile infection. Gut 68, 1791\u20131800 (2019).","journal-title":"Gut"},{"key":"60821_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/gast.1996.v110.pm8566593","volume":"110","author":"R Aldini","year":"1996","unstructured":"Aldini, R. et al. Intestinal absorption of bile acids in the rabbit: different transport rates in jejunum and ileum. Gastroenterology 110, 459\u2013468 (1996).","journal-title":"Gastroenterology"},{"key":"60821_CR32","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.molpharmaceut.8b00875","volume":"15","author":"EF Enright","year":"2018","unstructured":"Enright, E. F. et al. Gut microbiota-mediated bile acid transformations alter the cellular response to multidrug resistant transporter substrates in vitro: focus on p-glycoprotein. Mol. Pharm. 15, 5711\u20135727 (2018).","journal-title":"Mol. Pharm."},{"key":"60821_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.phrs.2018.08.008","volume":"135","author":"A S\u00e1nchez-Garc\u00eda","year":"2018","unstructured":"S\u00e1nchez-Garc\u00eda, A., Sahebkar, A., Simental-Mend\u00eda, M. & Simental-Mend\u00eda, L. E. Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trials. Pharmacol. Res. 135, 144\u2013149 (2018).","journal-title":"Pharmacol. Res."},{"key":"60821_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell, L. C. et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet 394, 849\u2013860 (2019).","journal-title":"Lancet"},{"key":"60821_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2016.10.011","volume":"6","author":"L Brooks","year":"2017","unstructured":"Brooks, L. et al. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol. Metab. 6, 48\u201360 (2017).","journal-title":"Mol. Metab."},{"key":"60821_CR36","unstructured":"RTL Genomics. Data Analysis Methodology for Microbial Diversity. https:\/\/static1.squarespace.com\/static\/5807c0ce579fb39e1dd6addd\/t\/5813af0fd482e97e5eb4fcb5\/1477685010205\/Data_Analysis_Methodology.pdf (2019)."},{"key":"60821_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymeth.2018.04.028","volume":"149","author":"BH Mullish","year":"2018","unstructured":"Mullish, B. H. et al. Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease. Methods 149, 49\u201358 (2018).","journal-title":"Methods"},{"key":"60821_CR38","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Env. Microbiol. 79, 5112\u20135120 (2013).","journal-title":"Appl. Env. Microbiol."},{"key":"60821_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jbiotec.2017.06.1198","volume":"261","author":"FO Gl\u00f6ckner","year":"2017","unstructured":"Gl\u00f6ckner, F. O. et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. J. Biotechnol. 261, 169\u2013176 (2017).","journal-title":"J. Biotechnol."},{"key":"60821_CR40","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Env. Microbiol. 73, 5261\u20135267 (2007).","journal-title":"Appl. Env. Microbiol."},{"key":"60821_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mimet.2016.02.001","volume":"123","author":"LS Morris","year":"2016","unstructured":"Morris, L. S. & Marchesi, J. R. Assessing the impact of long term frozen storage of faecal samples on protein concentration and protease activity. J. Microbiol. Methods 123, 31\u201338 (2016).","journal-title":"J. Microbiol. Methods"},{"key":"60821_CR42","doi-asserted-by":"publisher","first-page":"e85344","DOI":"10.1371\/journal.pone.0085344","volume":"9","author":"K Smith","year":"2014","unstructured":"Smith, K., Zeng, X. & Lin, J. Discovery of bile salt hydrolase inhibitors using an efficient high-throughput screening system. PLoS One 9, e85344 (2014).","journal-title":"PLoS One"},{"key":"60821_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","volume":"22","author":"V Tremaroli","year":"2015","unstructured":"Tremaroli, V. et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22, 228\u2013238 (2015).","journal-title":"Cell Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60821-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:54:38Z","timestamp":1695862478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60821-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60821-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GAB receives funding from Fractyl for research and as a consultant. Other authors report no competing interests relevant to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3895"}}